Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Delivering Health with Science: Huison Virgin DHA at the World Congress of Omega-3 Science & Technology 2021-11-16 21:30
Happiness Development Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency 2021-11-16 21:00
Molecular Stethoscope, Inc. Announces Presentation of Primary Sclerosing Cholangitis (PSC) Study at the AASLD Liver Meeting 2021 2021-11-16 19:00
Kazia Therapeutics Appoints John Friend, MD, as Chief Medical Officer 2021-11-16 00:00
R&D Milestone: HebaBiz Biotech's application for phase III clinical trial in China for Clevudine (L-FMAU), an anti-hepatitis B virus drug candidate under development has been approved 2021-11-15 22:47
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373 2021-11-15 22:39
CARsgen Announces CAR T-cell Product Candidate CT041 Granted PRIME Eligibility by the EMA 2021-11-15 22:10
Validation Study Showcases Success of LSBD's Rapid SARS-CoV-2 Antibody Test 2021-11-15 22:00
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients 2021-11-15 20:00
Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing 2021-11-15 19:00
Vazyme goes public on Shanghai Stock Exchange today 2021-11-15 16:28
Labcorp Opens New Integrated Laboratory, Strengthens Bioanalytical Services In Asia-Pacific 2021-11-15 16:00
InnoCare Announces the Clearance of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 by U.S. FDA 2021-11-15 08:30
Antengene Presents Compelling Preclinical Data on Two Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting on November 12, 2021 2021-11-15 08:25
China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results 2021-11-13 05:30
Research into gut microbiome-autism link reveals new perspective in collaborative Austism CRC study 2021-11-12 11:15
Recbio Announces Promising Preliminary Results From First-in-Human Study of a COVID-19 Vaccine Candidate With Novel Adjuvant BFA03 2021-11-12 07:55
Tabernacle Health Group Launches Revolutionary Immunity Booster. Natural Health Supplement Avrocil (TM) Treats Cold and Flu Symptoms caused by Upper Respiratory Tract Infections 2021-11-12 02:00
Lunit Presents Studies at SITC 2021, Highlighting the Effectiveness of AI in Predicting Response to Immunotherapy in a Clinical Trial Setting 2021-11-11 23:00
Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics 2021-11-11 21:33
1 198 199 200 201 202 440